Literature DB >> 24688937

Oxalate content of different drinkable dilutions of tea infusions after different brewing times.

Neda Lotfi Yagin1, Reza Mahdavi2, Zeinab Nikniaz1.   

Abstract

BACKGROUND: The aims of this study were to determine the effect of different brewing times and diluting on oxalate content of loose-packed black teas consumed in Tabriz, Iran.
METHODS: The oxalate content of black teas after brewing for 5, 10, 15, 30, 60 minutes was measured in triplicate by enzymatic assay. In order to attain the most acceptable dilution of tea infusions, tea samples which were brewed for 15, 30 and 60 minutes were diluted two (120 ml), three (80 ml) and four (60 ml) times respectively.
RESULTS: There was a stepwise increase in oxalate concentrations associated with increased brewing times (P< 0.001) with oxalate contents ranging from 4.4 mg/240 ml for the 5 min to 6.3 mg/240 ml for 60 min brewing times, respectively. There were significant differences between the mean oxalate content of different dilutions after brewing for 15, 30 and 60 minutes (P< 0.001).
CONCLUSION: The oxalate content of Iranian consumed black tea after different brewing times and different dilution was below the recommended levels. Therefore, it seems that consumption of black tea several times per day would not pose significant health risk in kidney stone patients and susceptible individuals.

Entities:  

Keywords:  Black tea; Brewing times; Different dilutions; Kidney stones; Oxalate

Year:  2012        PMID: 24688937      PMCID: PMC3963632          DOI: 10.5681/hpp.2012.026

Source DB:  PubMed          Journal:  Health Promot Perspect        ISSN: 2228-6497


  19 in total

1.  Tea oxalate.

Authors:  L K Massey
Journal:  Nutr Rev       Date:  2000-03       Impact factor: 7.110

Review 2.  Current aspects of epidemiology and nutrition in urinary stone disease.

Authors:  A Hesse; R Siener
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

3.  Study on the prevalence and incidence of urolithiasis in Germany comparing the years 1979 vs. 2000.

Authors:  A Hesse; E Brändle; D Wilbert; K-U Köhrmann; P Alken
Journal:  Eur Urol       Date:  2003-12       Impact factor: 20.096

4.  An improved HPLC-enzyme-reactor method for the determination of oxalic acid in complex matrices.

Authors:  R Hönow; D Bongartz; A Hesse
Journal:  Clin Chim Acta       Date:  1997-05-28       Impact factor: 3.786

Review 5.  Effect of dietary oxalate and calcium on urinary oxalate and risk of formation of calcium oxalate kidney stones.

Authors:  L K Massey; H Roman-Smith; R A Sutton
Journal:  J Am Diet Assoc       Date:  1993-08

6.  The frequency of urolithiasis in hospital discharge diagnoses in the United States.

Authors:  R Sierakowski; B Finlayson; R R Landes; C D Finlayson; N Sierakowski
Journal:  Invest Urol       Date:  1978-05

7.  The efficacy of dietary intervention on urinary risk factors for stone formation in recurrent calcium oxalate stone patients.

Authors:  Roswitha Siener; Natalie Schade; Claudia Nicolay; Gerd E von Unruh; Albrecht Hesse
Journal:  J Urol       Date:  2005-05       Impact factor: 7.450

8.  Tea consumption and cognitive impairment and decline in older Chinese adults.

Authors:  Tze-Pin Ng; Lei Feng; Mathew Niti; Ee-Heok Kua; Keng-Bee Yap
Journal:  Am J Clin Nutr       Date:  2008-07       Impact factor: 7.045

9.  Adult urolithiasis in a population-based study in Iran: prevalence, incidence, and associated risk factors.

Authors:  Mohammad Reza Safarinejad
Journal:  Urol Res       Date:  2007-03-15

Review 10.  A complementary approach to urolithiasis prevention.

Authors:  Robert A Anderson
Journal:  World J Urol       Date:  2002-10-17       Impact factor: 4.226

View more
  1 in total

1.  Does green tea consumption increase urinary oxalate excretion? Results of a prospective trial in healthy men.

Authors:  Kang Chen; Dong Chen; Chuangxin Lan; Xiongfa Liang; Tao Zeng; Jian Huang; Xiaolu Duan; Zhenzhen Kong; Shujue Li; Hans-Göran Tiselius; Alberto Gurioli; Xiaogang Lu; Guohua Zeng; Wenqi Wu
Journal:  Int Urol Nephrol       Date:  2017-10-19       Impact factor: 2.370

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.